TMCnet News

EQUITY ALERT: Nationally Ranked Rosen Law Reminds Obalon Therapeutics, Inc. Investors of Important Deadline in Class Action- OBLN
[February 23, 2018]

EQUITY ALERT: Nationally Ranked Rosen Law Reminds Obalon Therapeutics, Inc. Investors of Important Deadline in Class Action- OBLN


Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Obalon Therapeutics, Inc. (NASDAQ: OBLN) from October 5, 2016 through January 23, 2018, inclusive (the "Class Period") of the important April 16, 2018 lead plaintiff deadline. The lawsuit seeks to recover damages for Obalon investors under the federal securities laws.

To join the Obalon class action, go to http://rosenlegal.com/cases-1275.html or call Phillip Kim, Esq. or Daniel Sadeh, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, during the Class Period defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Oblon recognized revenue in violation of Generally Accepted Accounting Principles; (2) Obalon lacked adequate internal controls over accounting and financial reporting; and (3) as a result, defendants' statements about Obalon's business, operations, and prospects were materially false and misleading at all relevant times.



A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 16, 2018. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://rosenlegal.com/cases-1275.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Daniel Sadeh, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].

Follow us for updates on LinkedIn (News - Alert): https://www.linkedin.com/company/the-rosen-law-firm or on Twitter (News - Alert): https://twitter.com/rosen_firm.


Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Since 2014, Rosen Law Firm has been ranked #2 in the nation by Institutional Shareholder Services for the number of securities class action settlements annually obtained for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.


[ Back To TMCnet.com's Homepage ]